Cargando…
Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series
Acute viral pharyngitis (AVP) is a common respiratory illness affecting many individuals. Despite symptomatic treatment management of AVP, therapies are lacking to target a broad spectrum of viruses and the inflammatory nature of the disease. Available for many years, Chlorpheniramine Maleate (CPM),...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970260/ https://www.ncbi.nlm.nih.gov/pubmed/36860214 http://dx.doi.org/10.7759/cureus.34310 |
_version_ | 1784897886968872960 |
---|---|
author | Tesch, Mari L Dasgupta, Rahul Khawaja, Uzzam Ahmed Sanchez-Gonzalez, Marcos Franck, Rahaghi |
author_facet | Tesch, Mari L Dasgupta, Rahul Khawaja, Uzzam Ahmed Sanchez-Gonzalez, Marcos Franck, Rahaghi |
author_sort | Tesch, Mari L |
collection | PubMed |
description | Acute viral pharyngitis (AVP) is a common respiratory illness affecting many individuals. Despite symptomatic treatment management of AVP, therapies are lacking to target a broad spectrum of viruses and the inflammatory nature of the disease. Available for many years, Chlorpheniramine Maleate (CPM), is considered a low-cost and safe first-generation antihistamine displaying antiallergic, anti-inflammatory, and as of recently, identified as a broad-spectrum antiviral agent with activity against influenzas A/B viruses and SARS-CoV-2. Efforts have been made to identify repurposed drugs with favorable safety profiles that could significantly benefit the treatment of COVID-19-induced symptoms. The present case series highlights three patients in which a CPM-based throat spray was used to alleviate the symptoms of COVID-19-induced AVP. The CPM throat spray was associated with significant improvements in patient symptoms after approximately three days of use as opposed to the typical five to seven days reported elsewhere. While AVP is a self-limited syndrome and usually improves without pharmaceutical therapy, CPM throat spray may significantly reduce the overall time that the patient has symptoms. Additional clinical studies to evaluate the efficacy of CPM for the treatment of COVID-19-induced AVP are warranted. |
format | Online Article Text |
id | pubmed-9970260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-99702602023-02-28 Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series Tesch, Mari L Dasgupta, Rahul Khawaja, Uzzam Ahmed Sanchez-Gonzalez, Marcos Franck, Rahaghi Cureus Infectious Disease Acute viral pharyngitis (AVP) is a common respiratory illness affecting many individuals. Despite symptomatic treatment management of AVP, therapies are lacking to target a broad spectrum of viruses and the inflammatory nature of the disease. Available for many years, Chlorpheniramine Maleate (CPM), is considered a low-cost and safe first-generation antihistamine displaying antiallergic, anti-inflammatory, and as of recently, identified as a broad-spectrum antiviral agent with activity against influenzas A/B viruses and SARS-CoV-2. Efforts have been made to identify repurposed drugs with favorable safety profiles that could significantly benefit the treatment of COVID-19-induced symptoms. The present case series highlights three patients in which a CPM-based throat spray was used to alleviate the symptoms of COVID-19-induced AVP. The CPM throat spray was associated with significant improvements in patient symptoms after approximately three days of use as opposed to the typical five to seven days reported elsewhere. While AVP is a self-limited syndrome and usually improves without pharmaceutical therapy, CPM throat spray may significantly reduce the overall time that the patient has symptoms. Additional clinical studies to evaluate the efficacy of CPM for the treatment of COVID-19-induced AVP are warranted. Cureus 2023-01-28 /pmc/articles/PMC9970260/ /pubmed/36860214 http://dx.doi.org/10.7759/cureus.34310 Text en Copyright © 2023, Tesch et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Infectious Disease Tesch, Mari L Dasgupta, Rahul Khawaja, Uzzam Ahmed Sanchez-Gonzalez, Marcos Franck, Rahaghi Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title | Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title_full | Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title_fullStr | Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title_full_unstemmed | Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title_short | Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series |
title_sort | chlorpheniramine maleate throat spray for the treatment of covid-19-induced acute viral pharyngitis: case series |
topic | Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970260/ https://www.ncbi.nlm.nih.gov/pubmed/36860214 http://dx.doi.org/10.7759/cureus.34310 |
work_keys_str_mv | AT teschmaril chlorpheniraminemaleatethroatsprayforthetreatmentofcovid19inducedacuteviralpharyngitiscaseseries AT dasguptarahul chlorpheniraminemaleatethroatsprayforthetreatmentofcovid19inducedacuteviralpharyngitiscaseseries AT khawajauzzamahmed chlorpheniraminemaleatethroatsprayforthetreatmentofcovid19inducedacuteviralpharyngitiscaseseries AT sanchezgonzalezmarcos chlorpheniraminemaleatethroatsprayforthetreatmentofcovid19inducedacuteviralpharyngitiscaseseries AT franckrahaghi chlorpheniraminemaleatethroatsprayforthetreatmentofcovid19inducedacuteviralpharyngitiscaseseries |